EZH2 Mutations in Follicular Lymphoma from Different Ethnic Groups and Associated Gene Expression Alterations
Authors:
- Shuangping GuoSGShuangping Guo
- John K.C. ChanJCJohn K.C. Chan
- Javeed IqbalJIJaveed Iqbal
- Timothy McKeithanTMTimothy McKeithan
- Kai FuKFKai Fu
- Bin MengBMBin Meng
- Yi PanYPYi Pan
- Wah CheukWCWah Cheuk
- Donglan LuoDLDonglan Luo
- Ruian WangRWRuian Wang
- Weiwei ZhangWZWeiwei Zhang
- Timothy C. GreinerTGTimothy C. Greiner
Open Access
- 12 June 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 20 (12) , 3078-3086
Abstract
Purpose: Gain-of-function mutations of enhancer of Zeste homolog 2 (EZH2) occur frequently in diffuse large B-cell lymphomas and in follicular lymphomas. However, the frequency of EZH2 mutation in Chinese follicular lymphomas and the potential targets affected by this mutation are unknown. Experimental Design: We determined EZH2 codon 641 mutations in Chinese follicular lymphomas (n = 124) and compared them with Western follicular lymphomas (n = 70) using a sensitive pyrosequencing assay. Gene expression profiling (GEP) was performed to determine differential gene expression between the mutated versus unmutated subgroups, and selected genes were validated using immunohistochemistry. Results: Our results showed similar frequencies of EZH2 codon 641 mutations in Chinese and Western follicular lymphoma cohorts (16.9% vs. 18.6%, χ2 test, P = 0.773), including all five reported mutation variants. We observed significant association of EZH2 mutation with low morphologic grade follicular lymphomas (grade 1–2, 23.6% vs. grade 3, 7.7%, χ2 test, P = 0.02). EZH2 mutations also showed significant association with BCL2 rearrangement in the Chinese cohort (26.8% vs. 8.8%, χ2 test, P = 0.008) and combined cohorts (26.3% vs. 9.1%, χ2 test, P = 0.002). GEP analysis identified several genes, including TCF4, FOXP1, TCL1A, BIK, and RASSF6P, with significantly lower mRNA expression (P < 0.01) in mutated cases, and the potential target TCL1A showed consistent results at the protein level. Conclusion: Similar prevalence of EZH2 mutation in two ethnic groups suggests shared pathogenetic mechanisms. The much lower frequency of EZH2 mutation in cases without BCL2 translocation suggests a different pattern of evolution of this subtype of follicular lymphoma. GEP studies showed a set of differentially expressed genes and suggested that EZH2 mutation may help to lock the tumor cells at the germinal center stage of differentiation. Clin Cancer Res; 20(12); 3078–86. ©2014 AACR.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 casesBlood, 2012
- Frequencies of BCL2 and BCL6 Translocations in Representative Chinese Follicular Lymphoma PatientsDiagnostic Molecular Pathology, 2012
- Epidemiologic overview of malignant lymphomaThe Korean Journal of Hematology, 2012
- EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell LymphomasPLOS ONE, 2011
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylationBlood, 2011
- EZH2 Y641 mutations in follicular lymphomaLeukemia, 2011
- Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomasProceedings of the National Academy of Sciences of the United States of America, 2010
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center originNature Genetics, 2010
- Distribution of malignant lymphoma in Japan: Analysis of 2260 cases, 2001–2006Pathology International, 2008
- Epidemiology of the non-Hodgkin’s lymphomas: Distributions of the major subtypes differ by geographic locationsAnnals of Oncology, 1998